Ferrari S, Orlandi M, Avella M, Caldora P, Ferraro A, Ravazzolo G, Bacci G
Centro Tumori dell'Apparato Locomotore, Istituto Ortopedico Rizzoli, Bologna.
Minerva Med. 1992 May;83(5):289-93.
High dose of methotrexate (HDMTX) with leucovorin rescue requires over-hydratation to avoid nephrotoxicity; nevertheless the relationship between hydratation and plasma MTX levels is unknown. We compared the effects of two different types of hydratation (2 lt/m2 vs 1.5 lt/m2) on plasma MTX levels in two groups of patients with osteosarcoma of the extremities and treated with HDMTX (8 g/m2 IV). Samples were obtained at the end of infusion of MTX and 14 and 38 hours after the start of MTX infusion. At the end of infusion of MTX the medium plasma MTX levels proved significantly higher in the group with low hydratation than in the group with high hydratation (585.5 microns/l vs 427.7 microns/l P less than 0.001). The values obtained at 14 and 38 hours, did not show significant differences. No significant differences were seen between the two groups in term of late elimination of MTX and correlated toxicity. These data show that a low hydratation regime allows higher plasma MTX levels at the end of infusion of HDMTX and does not increase the incidence of late elimination of MTX compared to a high hydratation regime.
大剂量甲氨蝶呤(HDMTX)联合亚叶酸钙解救治疗时需要充分补液以避免肾毒性;然而,补液与血浆甲氨蝶呤水平之间的关系尚不清楚。我们比较了两组接受HDMTX(8 g/m²静脉注射)治疗的四肢骨肉瘤患者,两种不同补液量(2升/平方米 vs 1.5升/平方米)对血浆甲氨蝶呤水平的影响。在甲氨蝶呤输注结束时以及甲氨蝶呤输注开始后14小时和38小时采集样本。在甲氨蝶呤输注结束时,补液量少的组血浆甲氨蝶呤平均水平显著高于补液量多的组(585.5微摩尔/升 vs 427.7微摩尔/升,P<0.001)。在14小时和3八小时测得的值没有显著差异。两组在甲氨蝶呤的晚期清除及相关毒性方面没有显著差异。这些数据表明,与高补液方案相比,低补液方案在HDMTX输注结束时可使血浆甲氨蝶呤水平更高,且不会增加甲氨蝶呤晚期清除的发生率。